Heartflow, Inc. Revenue
Heartflow, Inc. (HTFL) reported Revenue of $64.08 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-08-13
- Heartflow, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $64.08M, a 47.57% increase year-over-year.
- Heartflow, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $52.59M, a 41.34% increase year-over-year.
- Heartflow, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $49.13M, a 40.46% increase year-over-year.
- Heartflow, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $46.28M, a 40.51% increase year-over-year.
- Heartflow, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2025 was $176.03M, a 39.92% increase from fiscal 2024.
- Heartflow, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2024 was $125.81M, a 44.32% increase from fiscal 2023.
- Heartflow, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $87.17M.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $64.08M 10-Q · filed 2026-08-13 | $116.67M 10-Q · filed 2026-08-13 | $165.80M derived: sum of 3 quarters · filed 2026-08-13 | $212.07M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $52.59M 10-Q · filed 2026-05-14 | $101.72M derived: sum of 2 quarters · filed 2026-05-14 | $147.99M derived: sum of 3 quarters · filed 2026-05-14 | $191.42M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $49.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $95.41M derived: sum of 2 quarters · filed 2026-03-18 | $138.83M derived: sum of 3 quarters · filed 2026-08-13 | $176.03M 10-K · filed 2026-03-18 |
| 2025-09-30 | $46.28M 10-Q · filed 2025-11-12 | $89.70M derived: sum of 2 quarters · filed 2026-08-13 | $126.90M 10-Q · filed 2025-11-12 | $161.88M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $43.42M 10-Q · filed 2026-08-13 | $80.63M 10-Q · filed 2026-08-13 | $115.61M derived: sum of 3 quarters · filed 2026-08-13 | $148.54M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $37.20M 10-Q · filed 2026-05-14 | $72.18M derived: sum of 2 quarters · filed 2026-05-14 | $105.12M derived: sum of 3 quarters · filed 2026-05-14 | $136.17M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $34.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $67.91M derived: sum of 2 quarters · filed 2026-03-18 | $98.97M derived: sum of 3 quarters · filed 2026-03-18 | $125.81M 10-K · filed 2026-03-18 |
| 2024-09-30 | $32.93M 10-Q · filed 2025-11-12 | $63.99M derived: sum of 2 quarters · filed 2025-11-12 | $90.83M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $31.05M 10-Q · filed 2025-09-19 | $57.90M 10-Q · filed 2025-09-19 | ||
| 2023-12-31 | $87.17M 10-K · filed 2026-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |